The Capillary Index Score Trial

Completed · Phase 1

Conditions studied: Acute Stroke, Brain Ischemia, Ischemic Stroke

In brief

This study seeks to investigate the capillary index score (CIS) to further improve patient selection of endovascular treatment (EVT) in acute ischemic stroke (AIS). The hypothesis or idea being tested: Patients with favorable CIS who are successfully revascularized with EVT can have successful outcomes with an extended time window for treatment.

Key facts

Study ID

NCT02618031

Run by

Firas Al-Ali

People needed

57

Starts

2016-03-01

Expected to finish

2018-12-31

Last updated by the study team

2020-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Anterior circulation acute ischemic stroke due to blockage of the intracranial internal carotid artery or middle cerebral artery (M1)
• Within 24 hours of onset of symptoms
• NIHSS Score is 8 or greater

You may not qualify if…

• Contra-indication for IAT found on initial CT
• Intracranial hemorrhage
• Stroke mimics (tumor, herpetic encephalitis, etc.)
• More than 1/3 hypodensity on non-enhanced head CT prior to intervention
• ASPECT Score less than 6
• Pre-existing disability defined as modified Rankin Scale (mRS) score more than 2
• Pregnant women

Where it is running

• WellStar Atlanta Medical System — Atlanta, Georgia, United States
• New York University Langone Medical Center — New York, New York, United States
• Rochester General Hospital — Rochester, New York, United States
• University of North Carolina Hospital — Chapel Hill, North Carolina, United States
• Akron General Medical Center — Akron, Ohio, United States
• University of Vermont Medical Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.